| Project | Indication | Target | Discovery | CMC Development |
IND enabling |
Phase I | Phase II | Phase III |
|---|---|---|---|---|---|---|---|---|
| HY-1608 | Postoperative Pain (iv) | Opiate partial triple agonist |
||||||
| Treatment-resistant depression | ||||||||
| Cancer pain (sc) | ||||||||
| HY-2216 | Chronic Pain | Non-opiate | ||||||
| HY-2518 | Postoperative Pain (oral) | Opiate quadruple agonist | ||||||
| Deubuprenorphine | OUD + Pain | Deuterated Buprenorphine | ||||||
| Deurotundine | Anti-addiction | Deuterated Rotundine | ||||||
| HY-2147 | Pain + Pruritus | Small molecule Peripheral K-agonist |
||||||
| HY-2160 | Prevention of CIPN | Butylphthalide derivative | ||||||